Investing Profile

David Rubin

VCInvestor
Managing Director at Merck Global Health Innovation Fund
msdghifund.comUnited States
Photo of David Rubin, Managing Director at Merck Global Health Innovation Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
17
CompanyStageDateRound SizeTotal Raised
N-Power Medicine
Series BMay 2024
Baseimmune
Series AFeb 2024$11M
$17M
Co-investors: Jamie Macfarlane (Creator Fund), Hussein Kanji (Hoxton Ventures)
Culmination Bio
Series ANov 2023$10M
$10M
Co-investors: Jack Boren
Octave
Series BJul 2023$33M
Series UnknownOct 2021
$150M
Co-investors: Michael Rubin (Northpond Ventures), Saurabh Bhansali (Health Velocity Capital), Mike Pellini (Section 32), Julian Harris (Deerfield Management)
Turbine
Series ANov 2022$21M
$130M
Co-investors: Alexandre Perrin (Scalebridge Capital), Anvesh Ramineni (MassMutual Ventures), Hany Nada (ACME Capital), Daniel Waterhouse (Balderton Capital), Christian Dahlen (Band of Angels), Vishal Gulati (Molten Ventures), Richard De Silva, Esther Dyson
PreciseDx
Series AJan 2022$11M
$14M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds)
Verge Genomics
Series BDec 2021$98M
$130M
Co-investors: Lan Xuezhao (Basis Set Ventures), Henry McNamara (Great Oaks Venture Capital), Andrew Boszhardt (Great Oaks Venture Capital), Jesse Beyroutey (IA Ventures), Kimberly Vogel
Ciox Health
Private EquityJul 2019$30M
$30M